Overview

Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus

Status:
Not yet recruiting
Trial end date:
2022-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the potential efficacy of topical ruxolitinib for the treatment of discoid lupus erythematosus (DLE)
Phase:
Phase 2
Details
Lead Sponsor:
University of Rochester
Collaborator:
Incyte Corporation